Chinonyerem Ogadi Iheanacho (Chinonyerem O Iheanacho)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 17

Top Topics

Systematic Review

Antimicrobial Resistance

Respiratory Syndrome Coronavirus

Angiotensin Converting Enzyme

Top Venues

Hospital pharmacy

American journal of men's health

Future journal of pharmaceutical sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Chinonyerem Ogadi Iheanacho, Valentine U Odili, Glen E Enakirerhi, Edoise M Isiwele, Akanimo Essiet
Pattern, Clinical Characteristics, and Impact of Family History on Prostate-Specific Antigen in Prostate Cancer: A Multicenter Study. American journal of men's health 18 (4) (2024)
Chinonyerem Ogadi Iheanacho, Adepeju Oluwaseyi Tugbobo, Uchenna I H Eze
Pharmaceutical Care in Mental Health: Pharmacists' Barriers, Collaborations, Attitudes, and Perceptions. Hospital pharmacy 59 (4) (2024)
Chinonyerem Ogadi Iheanacho, Okechukwu Harrison Enechukwu
Role of antihypertensive medicines in prostate cancer: a systematic review. BMC cancer 24 (1) (2024)
Chinonyerem Ogadi Iheanacho, Adepeju Oluwaseyi Tugbobo, Uchenna I H Eze
Pharmaceutical Care in Mental Health: Pharmacists' Barriers, Collaborations, Attitudes, and Perceptions. Hospital pharmacy 59 (4) (2024)
Chinonyerem Ogadi Iheanacho, Valentine U Odili, Glen E Enakirerhi, Edoise M Isiwele, Akanimo Essiet
Pattern, Clinical Characteristics, and Impact of Family History on Prostate-Specific Antigen in Prostate Cancer: A Multicenter Study. American journal of men's health 18 (4) (2024)
Chinonyerem Ogadi Iheanacho, Okechukwu Harrison Enechukwu
Role of antihypertensive medicines in prostate cancer: a systematic review. BMC cancer 24 (1) (2024)
Chinonyerem Ogadi Iheanacho, Adepeju Oluwaseyi Tugbobo, Uchenna I H Eze
Pharmaceutical Care in Mental Health: Pharmacists' Barriers, Collaborations, Attitudes, and Perceptions. Hospital pharmacy 59 (4) (2024)
Chinonyerem Ogadi Iheanacho, Adepeju Oluwaseyi Tugbobo, Uchenna I H Eze
Pharmaceutical Care in Mental Health: Pharmacists' Barriers, Collaborations, Attitudes, and Perceptions. Hospital pharmacy 59 (4) (2024)
Chinonyerem Ogadi Iheanacho, Okechukwu Harrison Enechukwu
Role of antihypertensive medicines in prostate cancer: a systematic review. BMC cancer 24 (1) (2024)
Chinonyerem Ogadi Iheanacho, Valentine U Odili, Glen E Enakirerhi, Edoise M Isiwele, Akanimo Essiet
Pattern, Clinical Characteristics, and Impact of Family History on Prostate-Specific Antigen in Prostate Cancer: A Multicenter Study. American journal of men's health 18 (4) (2024)
Chinonyerem Ogadi Iheanacho
"An antibiotic turned contraceptive": The tale of ampicillin-cloxacillin. Health science reports 5 (1) (2022)
Chinonyerem Ogadi Iheanacho, Uchenna I H Eze
Antimicrobial resistance in Nigeria: challenges and charting the way forward. European journal of hospital pharmacy : science and practice 29 (2) (2022)
Blessing Jaka Akombi-Inyang, Emma Woolley, Chinonyerem Ogadi Iheanacho, Khulan Bayaraa, Pramesh Raj Ghimire
Regional Trends and Socioeconomic Predictors of Adolescent Pregnancy in Nigeria: A Nationwide Study. International journal of environmental research and public health 19 (13) (2022)
Chinonyerem Ogadi Iheanacho, Uchenna I H Eze
Immunogenicity and clinical features relating to BNT162b2 messenger RNA COVID-19 vaccine, Ad26.COV2.S and ChAdOx1 adenoviral vector COVID-19 vaccines: a systematic review of non-interventional studies. Future journal of pharmaceutical sciences 8 (1) (2022)
Chinonyerem Ogadi Iheanacho, Okechukwu H Enechukwu
COVID-19-associated liver injury, role of drug therapy and management: a review. Egyptian liver journal 12 (1) (2022)
Chinonyerem Ogadi Iheanacho, Valentine U Odili, Uchenna I H Eze
Risk of SARS-CoV-2 infection and COVID-19 prognosis with the use of renin-angiotensin-aldosterone system (RAAS) inhibitors: a systematic review. Future journal of pharmaceutical sciences 7 (1) (2021)
Chinonyerem Ogadi Iheanacho, Uchenna I H Eze, Emmanuel A Adida
A systematic review of effectiveness of BNT162b2 mRNA and ChAdOx1 adenoviral vector COVID-19 vaccines in the general population. Bulletin of the National Research Centre 45 (1) (2021)